TIDES 2023: Addressing Complex Oligonucleotide Therapeutics and Approach Towards Endotoxin Removal

Developing next-generation oligonucleotide therapeuticsПодробнее

TIDES 2023: Advantages of Fujimat as Standalone Liquid Phase Synthesis ReagentПодробнее

TIDES 2023: How the Right-Size Oligosynthesizer is Crucial to Manufacturing ProductivityПодробнее

Supportive Oligonucleotide Therapy: The Future of Genetic MedicineПодробнее

Overcoming oligonucleotide manufacturing challenges, Trishul Shah, TIDES USA 2023Подробнее

Oligonucleotide pool synthesis with GenScriptПодробнее

Overcoming Oligonucleotide Manufacturing Challenges, Loïc Cornelissen, TIDES ASIAПодробнее

TIDES 2023: The Future of mRNA Technology, with Roche CustomBiotech's Dr. Neera SammetaПодробнее

What are oligonucleotide therapeutics, and how do they work?Подробнее

How Does It Work? | Oligonucleotide TherapiesПодробнее

Oligonucleotide and mRNA therapeutics with Anna Collén, AstraZenecaПодробнее

Overcoming oligonucleotide analysis challenges with IntertekПодробнее

TIDES 2023: PolypeptideПодробнее

The TIDES ExperienceПодробнее

2023 Annual Meeting HighlightsПодробнее